Answers are grounded in this paper and cite their sources.
Demonstrates enhanced prognostic scoring in chronic myeloid leukaemia by extending MR4 duration, implying better outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fujita et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: